Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting outcomes in patients with obstructive sleep apnea using hypoglossal nerve stimulation

Official title: Assessing Stimulated Upper Airway Mechanics to Predict Outcomes in Hypoglossal Nerve

Run by Johns Hopkins University · NCT05429983 · Data updated 2026-11-12

This study is trying to figure out how the upper airway works in people with obstructive sleep apnea to see why some don’t respond well to a specific treatment called hypoglossal nerve stimulation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedNovember 29, 2022
Main results expectedNovember 29, 2027
Study endsNovember 29, 2028
Registry record updatedDecember 24, 2025
Trial IDNCT05429983 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are males and females with moderate to severe obstructive sleep apnea who are undergoing DISE for HGNS evaluation.

Probably not a fit

Patients with significant cardiac, pulmonary, liver, or renal diseases, uncontrolled hypertension, neuromuscular diseases, major psychiatric disorders, or those who are pregnant or on anticoagulation therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize upper airway biomechanics and identify predictors of clinical responses to hypoglossal nerve stimulation (HGNS) therapy in patients with obstructive sleep apnea (OSA). Participants will include individuals undergoing drug-induced sleep endoscopy (DISE) as part of their evaluation for HGNS therapy. The study seeks to improve understanding of why some patients do not respond adequately to HGNS, despite being selected based on strict criteria. By analyzing upper airway mechanics, the study hopes to enhance patient selection and treatment outcomes for those intolerant to CPAP.

Why it matters

Potential benefit: If successful, this study could lead to improved patient selection for HGNS therapy, enhancing treatment outcomes for those with obstructive sleep apnea.

How similar studies have gone: While there have been studies on hypoglossal nerve stimulation, this specific approach focusing on upper airway biomechanics and predictors of response is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female participants with moderate or severe sleep apnea (defined by \> 15 apneas and hypopneas per hour of sleep), who are undergoing DISE as part of routine evaluation for Inspire hypoglossal nerve stimulation therapy or for ineffective HGNS therapy.

Exclusion Criteria:

* Significant cardiac disease, unstable or recent cardiac events
* Active pulmonary, liver or renal disease
* Uncontrolled hypertension (BP\>160/100)
* Neuromuscular disease
* Major psychiatric disease
* Pregnancy
* Anticoagulation therapy (e.g. Coumadin, Dabigatran)

Where it's running

  • Johns Hopkins Hospital
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Kevin Motz, MD — Johns Hopkins University
  • Study coordinator: Kevin M Motz
  • Email: kmotz1@jh.edu
  • Phone: 410614245

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.